π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The primary purpose of this study is to determine the safety and efficacy o...
Status
Unknown
Location
The Affiliated People's Hospital of Ningbo University
Start Date
2021-09-16
Trial ID
NCT05528887
Treatments Being Tested
This is a multi-center, open-label, non-randomized, phase I/II trial. Patie...
Status
Recruiting
Location
Beijing GoBroad Hospital
Start Date
2024-03-22
Trial ID
NCT06316427
To observe the efficacy and safety of CD7-targeted chimeric antigen recepto...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2025-08-18
Trial ID
NCT07280494
Treatments Being Tested
This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Start Date
2025-09-01
Trial ID
NCT07117305
Treatments Being Tested
To evaluate the tolerability and safety of SENL101 in patients with relapse...
Status
Recruiting
Location
Shanghai Ruijin Hospital
Start Date
2023-08-15
Trial ID
NCT06136364
Treatments Being Tested
The primary purpose of this study is to determine the safety and efficacy o...
Status
Withdrawn
Location
Shanghai Pudong Hospital, Fudan University Affiliated Pudong Medical Center
Start Date
2020-08-01
Trial ID
NCT05513612
Treatments Being Tested
This is a multi-center, open-label, non-randomized, single-arm clinical tri...
Status
Recruiting
Location
Beijing GoBroad Hospital
Start Date
2025-04-01
Trial ID
NCT06925464
Treatments Being Tested
This is a phase 1 clinical trial of autologous CD7-CAR T cells in the treat...
Status
Completed
Location
Beijing Boren Hospital
Start Date
2021-09-14
Trial ID
NCT04840875
Treatments Being Tested
To observe the efficacy and safety of CD7-targeted chimeric antigen recepto...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2025-08-18
Trial ID
NCT07143929
Treatments Being Tested
Phase I was a single arm, open label, dose increasing study to explore the ...
Status
Unknown
Location
First Affiliated Hospital of Zhengzhou University
Start Date
2020-11-24
Trial ID
NCT04480788
Treatments Being Tested